On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


PV Nano Cell (PVNNF) Increases IP War Chest as Japanese Patent Office Grants Silver Nano Particles Patent for 3D Printing

A recent Forbes (http://dtn.fm/2WfWR) article shows just how far Additive Manufacturing (AM), a.k.a. 3D Printing, has come, reporting that the government of Dubai, United Arab Emirates, ‘has set a target for 25 percent of buildings to be 3D-printed by 2030.’ Apparently, the AM industry now believes it has the technology to “print” houses. That technological prowess also appears to extend to smaller objects, much smaller, where the challenges are different but just as formidable. An Economist feature (http://dtn.fm/71FDh) tells how a Chinese contract manufacturer is using 3D printers ‘to print electronic circuits, such as antennae and sensors, directly into products instead of making those components separately and assembling them into the devices.’ Printers need ink, however, and 3D printers need the special kind produced by PV Nano Cell (OTCQB: PVNNF). Under the Sicrys™ brand, the innovative Israeli outfit has developed a menu of customized single crystal nanometric conductive inks for use in the manufacture of a wide range of electronic devices.

The devices that PVNNF’s inks are designed to work with are less than Lilliputian. A nanometer is one-billionth of a meter or, put another way, it would take 25,400,000 nanometers in a line to cover a distance of just one inch. These tiny devices are, more often than not, required to transmit electrical signals and, consequently, need conductive inks of quality. Sicrys™ inks serve a wide range of applications that demand high-performance conductive inks, including mass produced printed electronics applications such as printed circuit boards, antennas, sensors, and touch screens, as well as photovoltaic applications, and are available in both silver-based and copper-based formulations.

PVNNF is bolstering its intellectual property (IP) war chest with a plethora of patents. In May 2017, the company announced (http://dtn.fm/xVPO4) that the Japanese Patent Office (JPO) had granted its silver nano particles patent. The company has already been granted patents in four countries for its silver single crystal nano particles based dispersions and inks and has submitted patents related to its silver and copper nano particles in nine other countries. To date, PVNNF has submitted patent applications for both its silver and copper nano particles in Brazil, China, Europe, India, Israel, Japan, Russia, South Korea, the United Kingdom and the U.S.

Owing to its general applicability, the Sicrys™ portfolio of conductive inks is appearing in many potentially lucrative market segments. For example, the market for “printing” antennas is about $0.5 billion, while for photovoltaic (PV) metallization it’s about $1.8 billion. For flexible and customized electronics, market size is estimated at around $2.0 billion, and for printed circuit boards (PCB) it is about $6.0 billion. The inks are already in use. Albuquerque, New Mexico-based Optomec prints antennas for the mobile industry using Sicrys™ inks, and Stratasys, a pioneer in developing 3D printing technologies, uses Sicrys™ too, as does inkjet technology provider Pixdro.

In the world of 3D printing, PV Nano Cell’s Sicrys™ ink family is hot off the press. The company continues its quest to develop the very best conductive inks for use in solar PV and printed electronics applications.

For more information, please visit www.PVNanoCell.com

From Our Blog

Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update

March 28, 2024

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for life-threatening conditions with unmet medical needs, recently released its full-year results for the period ended December 31, 2023, and provided a corporate update (https://ibn.fm/iORBu). Results from multiple studies using Longeveron’s lead investigational therapeutic candidate, Lomecel-B(TM), were announced by the company last year. “In 2023 […]

Rotate your device 90° to view site.